Biological E acquires Akorn India to ramp up vaccine & injectable medicine capacities
Posted by
www.biotecnika.org
Akorn India, a subsidiary of the US-based Akorn Inc., has a
manufacturing plant of 39,000 square metres over a 14-acre campus in
Himachal Pradesh with an annual capacity for about 135 million units.
BE said the Akorn India facility has the potential for immediate
expansion of a further 30 million units.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biological-e-acquires-akorn-india-to-ramp-up-vaccine-injectable-medicine-capacities/articleshow/77590742.cms
Subscribe to:
Post Comments (Atom)
Post a Comment